Last reviewed · How we verify

NCT06197997: REC

Resilient, Engaged, and Connected Study

Recruiting now NA Last updated 9 March 2026
What this trial tests

NA trial testing Chicago Parent Program (CPP) in Parenting in 840 participants. Currently enrolling.

Timeline
1 September 2024
Primary endpoint
30 June 2028
30 June 2028

Quick facts

Lead sponsorJohns Hopkins University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment840
Start date1 September 2024
Primary completion30 June 2028
Estimated completion30 June 2028
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Parenting or Parenting Intervention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose of this study is to test the effectiveness and implementation of an evidence-based parenting intervention for improving parenting and school outcomes in a sample of 4-5-year-old children enrolled in public prekindergarten (PreK) programs in Maryland.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Resilient, engaged and connected (REC) study: protocol for a type 2 cluster-randomised trial of the Chicago Parent Program in prekindergarten in low-income urban and rural communities.
    Gross D, Breitenstein SM, Jeon L, Perrin N, et al · · 2025 · PMID 40246571 · DOI 10.1136/bmjopen-2025-099204

Verify or expand the search:

Other recruiting trials for Parenting

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06197997.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing